Methods_Monocytes and adalimumab in HS

Published: 27 August 2024| Version 1 | DOI: 10.17632/9g66g9k65c.1
Contributor:
Nessr Abu Rached

Description

Further information on the methodology from the article with the title “Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study” by Nessr Abu Rached et al.

Files

Categories

Hidradenitis Suppurativa

Licence